This work is licensed under a Creative Commons Attribution 4.0 International License.
LL-37 (17-29) [R23L,I24L,D26K,F27L]
General Information
DRACP ID DRACP02881
Peptide Name LL-37 (17-29) [R23L,I24L,D26K,F27L]
Sequence FKRIVQLLKKLLR
Sequence Length 13
UniProt ID P49913
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| A549 | Lung adenocarcinoma | Carcinoma | IC50=12.8 μg/ml | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: HC50=411 µg/ml
Normal (non-cancerous) Cytotoxicity DLF lung fibroblasts: IC50=23.7 μg/ml
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C79H143N23O15
Absent amino acids ACDEGHMNPSTWY
Common amino acids L
Mass 186938
Pl 12.55
Basic residues 5
Acidic residues 0
Hydrophobic residues 7
Net charge 5
Boman Index -2041
Hydrophobicity 19.23
Aliphatic Index 172.31
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32567085
Title Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents
Doi 10.1002/psc.3254
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_17799
This work is licensed under a Creative Commons Attribution 4.0 International License.